American Society of Hematology (ASH)

Individuals with severe sickle cell disease express high risk tolerance for gene therapies

[ad_1] Newswise — WASHINGTON, Oct. 31, 2023 – Individuals living with severe sickle cell disease (SCD) are highly interested in…